Platelets are anucleate blood cells that are involved in hemostasis and thrombosis. Although no longer able to generate ribonucleic acid (RNA) de novo, platelets contain messenger RNA (mRNA), YRNA fragments, and premature microRNAs (miRNAs) that they inherit from megakaryocytes.
Recent Advances:
Novel sequencing techniques have helped identify the unexpectedly large number of RNA species present in platelets. Throughout their life time, platelets can process the pre-existing pool of premature miRNA to give the fully functional miRNA that can regulate platelet protein expression and function.
Critical Issues:
Platelets make a major contribution to the circulating miRNA pool but platelet activation can have major consequences on Dicer levels and thus miRNA maturation, which has implications for studies that are focused on screening-stored platelets.
Future Directions:
It will be important to determine the importance of platelets as donors for miRNA-containing microvesicles that can be taken up and processed by other (particularly vascular) cells, thus contributing to homeostasis as well as disease progression. Antioxid. Redox Signal. 29, 902–921.
Get full access to this article
View all access options for this article.
References
1.
AkersJC, GondaD, KimR, CarterBS, and ChenCC. Biogenesis of extracellular vesicles (EV): Exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol, 113: 1–11, 2013.
2.
AlhasanAA, IzuoguOG, Al-BaloolHH, SteynJS, EvansA, ColzaniM, GhevaertC, MountfordJC, MarenahL, ElliottDJ, Santibanez-KorefM, and JacksonMS. Circular RNA enrichment in platelets is a signature of transcriptome degradation. Blood, 127: e1–e11, 2016.
3.
AndersonDM, AndersonKM, ChangCL, MakarewichCA, NelsonBR, McAnallyJR, KasaragodP, SheltonJM, LiouJ, Bassel-DubyR, and OlsonEN. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell, 160: 595–606, 2015.
ArraudN, LinaresR, TanS, GounouC, PasquetJM, MornetS, and BrissonAR. Extracellular vesicles from blood plasma: Determination of their morphology, size, phenotype and concentration. J Thromb Haemost, 12: 614–627, 2014.
6.
ArroyoJD, ChevilletJR, KrohEM, RufIK, PritchardCC, GibsonDF, MitchellPS, BennettCF, Pogosova-AgadjanyanEL, StirewaltDL, TaitJF, and TewariM. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A, 108: 5003–5008, 2011.
AucherA, RudnickaD, and DavisDM. MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation. J Immunol, 191: 6250–6260, 2013.
9.
AwwadK, HuJ, ShiL, MangelsN, AbdelMR, ZippelN, FisslthalerB, EbleJA, PfeilschifterJ, PoppR, and FlemingI. Role of secreted modular calcium-binding protein 1 (SMOC1) in transforming growth factor β signalling and angiogenesis. Cardiovasc Res, 106: 284–294, 2015.
10.
BasseF, GaffetP, and BienvenueA. Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: Are vesicles shed by filopod fragmentation?. Biochim Biophys Acta, 1190: 217–224, 1994.
11.
BijakM, DzieciolM, RywaniakJ, SalukJ, and ZielinskaM. Platelets miRNA as a prediction marker of thrombotic episodes. Dis Markers, 2016: 2872507, 2016.
12.
BoettgerT, BeetzN, KostinS, SchneiderJ, KrugerM, HeinL, and BraunT. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest, 119: 2634–2647, 2009.
13.
BohnsackMT, CzaplinskiK, and GorlichD. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA, 10: 185–191, 2004.
14.
BoilardE, DuchezAC, and BrissonA. The diversity of platelet microparticles. Curr Opin Hematol, 22: 437–444, 2015.
15.
BrayPF, McKenzieSE, EdelsteinLC, NagallaS, DelgrossoK, ErtelA, KupperJ, JingY, LondinE, LoherP, ChenHW, FortinaP, and RigoutsosI. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics, 14: 1, 2013.
16.
BrissonAR, TanS, LinaresR, GounouC, and ArraudN. Extracellular vesicles from activated platelets: A semiquantitative cryo-electron microscopy and immuno-gold labeling study. Platelets. 1–9, 2017.
17.
BurnierL, FontanaP, KwakBR, and Angelillo-ScherrerA. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost, 101: 439–451, 2009.
ChenJS, LiHC, LinSI, YangCH, ChienWY, SyuCL, and LoSY. Cleavage of Dicer protein by I7 protease during vaccinia virus infection. PLoS One, 10: e0120390, 2015.
20.
ChenL, WangJ, WangB, YangJ, GongZ, ZhaoX, ZhangC, and DuK. MiR-126 inhibits vascular endothelial cell apoptosis through targeting PI3K/Akt signaling. Ann Hematol, 95: 365–374, 2016.
21.
ChenY, SongY, HuangJ, QuM, ZhangY, GengJ, ZhangZ, LiuJ, and YangGY. Increased circulating exosomal miRNA-223 is associated with acute ischemic stroke. Front Neurol, 8: 57, 2017.
22.
ChendrimadaTP, GregoryRI, KumaraswamyE, NormanJ, CoochN, NishikuraK, and ShiekhattarR. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature, 436: 740–744, 2005.
23.
ChoKJ, SongJ, OhY, and LeeJE. MicroRNA-Let-7a regulates the function of microglia in inflammation. Mol Cell Neurosci, 68: 167–176, 2015.
24.
ChuM, WuR, QinS, HuaW, ShanZ, RongX, ZengJ, HongL, SunY, LiuY, LiW, WangS, and ZhangC. Bone marrow-derived microRNA-223 works as an endocrine genetic signal in vascular endothelial cells and participates in vascular injury from Kawasaki disease. J Am Heart Assoc, 6: e004878, 2017.
25.
ChyrchelB, Toton-ZuranskaJ, KruszelnickaO, ChyrchelM, MieleckiW, Kolton-WrozM, WolkowP, and SurdackiA. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report. Platelets, 26: 593–597, 2015.
ClimentM, QuintavalleM, MiragoliM, ChenJ, CondorelliG, and EliaL. TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization. Circ Res, 116: 1753, 2015.
29.
CocucciE, RacchettiG, and MeldolesiJ. Shedding microvesicles: Artefacts no more. Trends Cell Biol, 19: 43–51, 2009.
30.
CollartC, ChristovCP, SmithJC, and KrudeT. The midblastula transition defines the onset of Y RNA-dependent DNA replication in Xenopus laevis. Mol Cell Biol, 31: 3857–3870, 2011.
31.
CominettiMR, MartinAC, RibeiroJU, DjaafriI, Fauvel-LafeveF, CrepinM, and Selistre-de-AraujoHS. Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions. Biochimie, 91: 1045–1052, 2009.
32.
CorreiaCN, NalpasNC, McLoughlinKE, BrowneJA, GordonSV, MacHughDE, and ShaughnessyRG. Circulating microRNAs as potential biomarkers of infectious disease. Front Immunol, 8: 118, 2017.
33.
de BoerHC, van SolingenC, PrinsJ, DuijsJMGJ, HuismanMV, RabelinkTJ, and van ZonneveldAJ. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J, 34: 3451–3457, 2013.
34.
DenbyL and BakerAH. Targeting non-coding RNA for the therapy of renal disease. Curr Opin Pharmacol, 27: 70–77, 2016.
DerrienT, JohnsonR, BussottiG, TanzerA, DjebaliS, TilgnerH, GuernecG, MartinD, MerkelA, KnowlesDG, LagardeJ, VeeravalliL, RuanX, RuanY, LassmannT, CarninciP, BrownJB, LipovichL, GonzalezJM, ThomasM, DavisCA, ShiekhattarR, GingerasTR, HubbardTJ, NotredameC, HarrowJ, and GuigoR. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res, 22: 1775–1789, 2012.
37.
DhahbiJM. Circulating small noncoding RNAs as biomarkers of aging. Ageing Res Rev, 17: 86–98, 2014.
38.
DhahbiJM, SpindlerSR, AtamnaH, BoffelliD, MoteP, and MartinDI. 5′-YRNA fragments derived by processing of transcripts from specific YRNA genes and pseudogenes are abundant in human serum and plasma. Physiol Genomics, 45: 990–998, 2013.
DuanX, ZhanQ, SongB, ZengS, ZhouJ, LongY, LuJ, LiZ, YuanM, ChenX, YangQ, and XiaJ. Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke. J Diabetes Complications, 28: 705–710, 2014.
41.
EbbesenKK, HansenTB, and KjemsJ. Insights into circular RNA biology. RNA Biol, 16: 1–11, 2016.
42.
EkenC, GasserO, ZenhaeusernG, OehriI, HessC, and SchifferliJA. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. J Immunol, 180: 817–824, 2008.
43.
EkenC, SadallahS, MartinPJ, TrevesS, and SchifferliJA. Ectosomes of polymorphonuclear neutrophils activate multiple signaling pathways in macrophages. Immunobiology, 218: 382–392, 2013.
44.
ElgheznawyA, ShiL, HuJ, WittigI, LabanH, PircherJ, MannA, ProvostP, RandriamboavonjyV, and FlemingI. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes. Circ Res, 117: 157–165, 2015.
45.
FejesZ, PóliskaS, CzimmererZ, KáplárM, PenyigeA, Gál SzabóG, Beke DebreceniI, KunapuliSP, KappelmayerJ, and NagyBJr.Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus. Thromb Haemost, 117: 529–542, 2017.
46.
This reference has been deleted.
47.
FelliN, PediniF, RomaniaP, BiffoniM, MorsilliO, CastelliG, SantoroS, ChicarellaS, SorrentinoA, PeschleC, and MarzialiG. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica, 94: 479–486, 2009.
48.
FichtlschererS, DeRS, FoxH, SchwietzT, FischerA, LiebetrauC, WeberM, HammCW, RoxeT, Muller-ArdoganM, BonauerA, ZeiherAM, and DimmelerS. Circulating microRNAs in patients with coronary artery disease. Circ Res, 107: 677–684, 2010.
FoxJE, AustinCD, ReynoldsCC, and SteffenPK. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem, 266: 13289–13295, 1991.
51.
FreitasRCCd, BortolinRH, LopesMB, HirataMH, HirataRDC, SilbigerVN, and LuchessiAD. Integrated analysis of miRNA and mRNA gene expression microarrays: Influence on platelet reactivity, clopidogrel response and drug-induced toxicity. Gene, 593: 172–178, 2016.
52.
GarzonR, PichiorriF, PalumboT, IulianoR, CimminoA, AqeilanR, VoliniaS, BhattD, AlderH, MarcucciG, CalinGA, LiuCG, BloomfieldCD, AndreeffM, and CroceCM. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Nat Acad Sci U S A, 103: 5078–5083, 2006.
53.
GasserO and SchifferliJA. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood, 104: 2543–2548, 2004.
54.
GeX, ZhaoX, NakagawaA, GongX, Skeen-GaarRR, ShiY, GongH, WangX, and XueD. A novel mechanism underlies caspase-dependent conversion of the dicer ribonuclease into a deoxyribonuclease during apoptosis. Cell Res, 24: 218–232, 2014.
55.
GhodgaonkarMM, ShahRG, Kandan-KulangaraF, AffarEB, QiHH, WiemerE, and ShahGM. Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1. Cell Death Differ, 16: 858–868, 2009.
56.
GidlofO, van der BrugM, OhmanJ, GiljeP, OldeB, WahlestedtC, and ErlingeD. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood, 121: 3908–3926, 2013.
57.
GnatenkoDV, DunnJJ, SchwedesJ, and BahouWF. Transcript profiling of human platelets using microarray and serial analysis of gene expression (SAGE). Methods Mol Biol, 496: 245–272, 2009.
58.
GorenY, MeiriE, HoganC, MitchellH, LebanonyD, SalmanN, SchliamserJE, and AmirO. Relation of reduced expression of MiR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure. Am J Cardiol, 113: 976–981, 2014.
59.
GrahamGJ, RenQ, DilksJR, BlairP, WhiteheartSW, and FlaumenhaftR. Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo. Blood, 114: 1083–1090, 2009.
60.
Guimaraes-SternbergC, MeersonA, ShakedI, and SoreqH. MicroRNA modulation of megakaryoblast fate involves cholinergic signaling. Leuk Res, 30: 583–595, 2006.
61.
HergenreiderE, HeydtS, TreguerK, BoettgerT, HorrevoetsAJ, ZeiherAM, SchefferMP, FrangakisAS, YinX, MayrM, BraunT, UrbichC, BoonRA, and DimmelerS. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol, 14: 249–256, 2012.
62.
HirotaT, MorisakiT, NishiyamaY, MarumotoT, TadaK, HaraT, MasukoN, InagakiM, HatakeyamaK, and SayaH. Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J Cell Biol, 149: 1073–1086, 2000.
63.
HizirZ, BottiniS, GrandjeanV, TrabucchiM, and RepettoE. RNY (YRNA)-derived small RNAs regulate cell death and inflammation in monocytes/macrophages. Cell Death Dis, 8: e2530, 2017.
64.
HoffmannPR, deCathelineauAM, OgdenCA, LeverrierY, BrattonDL, DalekeDL, RidleyAJ, FadokVA, and HensonPM. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol, 155: 649, 2001.
65.
HuisseMG, AjzenbergN, FeldmanL, GuillinMC, and StegPG. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction. Thromb Haemost, 101: 734–740, 2009.
66.
HulsmansM and HolvoetP. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res, 100: 7–18, 2013.
67.
IchigozakiY, FukushimaS, JinninM, MiyashitaA, NakaharaS, TokuzumiA, YamashitaJ, KajiharaI, AoiJ, MasuguchiS, ZhongzhiW, and IhnH. Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma. Exp Dermatol, 25: 67–69, 2016.
68.
ItalianoJEJr, MairuhuAT, and FlaumenhaftR. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol, 17: 578–584, 2010.
JainS, KapetanakiMG, RaghavachariN, WoodhouseK, YuG, BargeS, CoronnelloC, BenosPV, KatoGJ, KaminskiN, and GladwinMT. Expression of regulatory platelet microRNAs in patients with sickle cell disease. PLoS One, 8: e60932, 2013.
71.
JansenF, StumpfT, ProebstingS, FranklinBS, WenzelD, PfeiferP, FlenderA, SchmitzT, YangX, FleischmannBK, NickenigG, and WernerN. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6. J Mol Cell Cardiol, 104: 43–52, 2017.
72.
JansenF, YangX, BaumannK, PrzybillaD, SchmitzT, FlenderA, PaulK, AlhusseinyA, NickenigG, and WernerN. Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism. J Cell Mol Med, 19: 2202–2214, 2015.
73.
JohnnidisJB, HarrisMH, WheelerRT, Stehling-SunS, LamMH, KirakO, BrummelkampTR, FlemingMD, and CamargoFD. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature, 451: 1125–1129, 2008.
74.
JohnstoneRM, AdamM, HammondJR, OrrL, and TurbideC. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem, 262: 9412–9420, 1987.
75.
KamatV, PaluruP, MyintM, FrenchDL, GadueP, and DiamondSL. MicroRNA screen of human embryonic stem cell differentiation reveals miR-105 as an enhancer of megakaryopoiesis from adult CD34+ cells. Stem Cells, 32: 1337–1346, 2014.
76.
KaudewitzD, SkroblinP, BenderLH, BarwariT, WilleitP, PechlanerR, SunderlandNP, WilleitK, MortonAC, ArmstrongPC, ChanMV, LuR, YinX, GracioF, DudekK, LangleySR, ZampetakiA, de RinaldisE, YeS, WarnerTD, SaxenaA, KiechlS, StoreyRF, and MayrM. Association of microRNAs and YRNAs with platelet function. Circ Res, 118: 420–432, 2016.
77.
KerrJF, WyllieAH, and CurrieAR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 26: 239–257, 1972.
78.
KohlstedtK, TrouvainC, BoettgerT, ShiL, FisslthalerB, and FlemingI. AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145. Circ Res, 112: 1150–1158, 2013.
79.
KondkarAA, BrayMS, LealSM, NagallaS, LiuDJ, JinY, DongJF, RenQ, WhiteheartSW, ShawC, and BrayPF. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: Suggested role for platelet microRNA. J Thromb Haemost, 8: 369–378, 2010.
80.
KopplerB, CohenC, SchlondorffD, and MackM. Differential mechanisms of microparticle transfer toB cells and monocytes: Anti-inflammatory propertiesof microparticles. Eur J Immunol, 36: 648–660, 2006.
81.
KoupenovaM, VitsevaO, MacKayCR, BeaulieuLM, BenjaminEJ, MickE, Kurt-JonesEA, RavidK, and FreedmanJE. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood, 124: 791–802, 2014.
82.
KrolJ, LoedigeI, and FilipowiczW. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet, 11: 597–610, 2010.
83.
KrudeT, ChristovCP, HyrienO, and MarheinekeK. Y RNA functions at the initiation step of mammalian chromosomal DNA replication. J Cell Sci, 122: 2836–2845, 2009.
LaffontB, CorduanA, PléH, DuchezAC, CloutierN, BoilardE, and ProvostP. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood, 122: 253–261, 2013.
86.
LandryP, PlanteI, OuelletDL, PerronMP, RousseauG, and ProvostP. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol, 16: 961–966, 2009.
87.
LehmannSM, KrugerC, ParkB, DerkowK, RosenbergerK, BaumgartJ, TrimbuchT, EomG, HinzM, KaulD, HabbelP, KalinR, FranzoniE, RybakA, NguyenD, VehR, NinnemannO, PetersO, NitschR, HeppnerFL, GolenbockD, SchottE, PloeghHL, WulczynFG, and LehnardtS. An unconventional role for miRNA: Let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci, 15: 827–835, 2012.
88.
LeiersederS, PetzoldT, ZhangL, LoyerX, MassbergS, and EngelhardtS. MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost, 110: 1207–1214, 2013.
89.
LemckeH, SteinhoffG, and DavidR. Gap junctional shuttling of miRNA—A novel pathway of intercellular gene regulation and its prospects in clinical application. Cell Signal, 27: 2506–2514, 2015.
90.
LewisBP, BurgeCB, and BartelDP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120: 15–20, 2005.
91.
LiH, FanJ, YinZ, WangF, ChenC, and WangDW. Identification of cardiac-related circulating microRNA profile in human chronic heart failure. Oncotarget, 7: 33–45, 2016.
92.
LiQ, HuB, HuGW, ChenCY, NiuX, LiuJ, ZhouSM, ZhangCQ, WangY, and DengZF. tRNA-derived small non-coding RNAs in response to ischemia inhibit angiogenesis. Sci Rep, 6: 20850, 2016.
LondinE, LoherP, TelonisAG, QuannK, ClarkP, JingY, HatzimichaelE, KirinoY, HondaS, LallyM, RamratnamB, ComstockCE, KnudsenKE, GomellaL, SpaethGL, HarkL, KatzLJ, WitkiewiczA, RostamiA, JimenezSA, HollingsworthMA, YehJJ, ShawCA, McKenzieSE, BrayP, NelsonPT, ZupoS, VanRK, KeatingMJ, CalinGA, YeoC, JimboM, CozzitortoJ, BrodyJR, DelgrossoK, MattickJS, FortinaP, and RigoutsosI. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A, 112: E1106–E1115, 2015.
95.
LondinER, HatzimichaelE, LoherP, EdelsteinL, ShawC, DelgrossoK, FortinaP, BrayPF, McKenzieSE, and RigoutsosI. The human platelet: Strong transcriptome correlations among individuals associate weakly with the platelet proteome. Biol Direct, 9: 3, 2014.
96.
LoscheW, ScholzT, TemmlerU, OberleV, and ClausRA. Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets, 15: 109–115, 2004.
97.
LuH, BuchanRJ, and CookSA. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res, 86: 410–420, 2010.
98.
LuJ, GuoS, EbertBL, ZhangH, PengX, BoscoJ, PretzJ, SchlangerR, WangJY, MakRH, DombkowskiDM, PrefferFI, ScaddenDT, and GolubTR. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell, 14: 843–853, 2008.
99.
LugliG, LarsonJ, MartoneME, JonesY, and SmalheiserNR. Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. J Neurochem, 94: 896–905, 2005.
100.
LugliG, TorvikVI, LarsonJ, and SmalheiserNR. Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. J Neurochem, 106: 650–661, 2008.
101.
MansfieldMW, KohlerHP, AriensRA, McCormackLJ, and GrantPJ. Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care, 23: 703–705, 2000.
102.
MatskevichAA and MoellingK. Stimuli-dependent cleavage of Dicer during apoptosis. Biochem J, 412: 527–534, 2008.
103.
MatsuzakiJ and OchiyaT. Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: A systematic review. Int J Clin Oncol, 22: 413–420, 2017.
104.
MauseSF and WeberC. Microparticles: Protagonists of a novel communication network for intercellular information exchange. Circ Res, 107: 1047–1057, 2010.
105.
McRedmondJP, ParkSD, ReillyDF, CoppingerJA, MaguirePB, ShieldsDC, and FitzgeraldDJ. Integration of proteomics and genomics in platelets: A profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics, 3: 133–144, 2004.
106.
MeiY, YongJ, LiuH, ShiY, MeinkothJ, DreyfussG, and YangX. tRNA binds to cytochrome c and inhibits caspase activation. Mol Cell, 37: 668–678, 2010.
107.
MeijerHA, KongYW, LuWT, WilczynskaA, SpriggsRV, RobinsonSW, GodfreyJD, WillisAE, and BushellM. Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science, 340: 82–85, 2013.
108.
MerkerovaM, BelickovaM, and BruchovaH. Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol, 81: 304–310, 2008.
109.
MichellDL and VickersKC. HDL and microRNA therapeutics in cardiovascular disease. Pharmacol Ther, 168: 43–52, 2016.
110.
MickE, ShahR, TanriverdiK, MurthyV, GersteinM, RozowskyJ, KitchenR, LarsonMG, LevyD, and FreedmanJE. Stroke and circulating extracellular RNAs. Stroke, 48: 828, 2017.
111.
MoldovanL, BatteKE, TrgovcichJ, WislerJ, MarshCB, and PiperM. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med, 18: 371–390, 2014.
NavickasR, GalD, LauceviciusA, TaparauskaiteA, ZdanyteM, and HolvoetP. Identifying circulating microRNAs as biomarkers of cardiovascular disease: A systematic review. Cardiovasc Res, 111: 322–337, 2016.
114.
NomuraS. Extracellular vesicles and blood diseases. Int J Hematol, 105: 392–405, 2017.
115.
NomuraS, SuzukiM, KatsuraK, XieGL, MiyazakiY, MiyakeT, KidoH, KagawaH, and FukuharaS. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis, 116: 235–240, 1995.
116.
OpalinskaJB, BersenevA, ZhangZ, SchmaierAA, ChoiJ, YaoY, D'SouzaJ, TongW, and WeissMJ. MicroRNA expression in maturing murine megakaryocytes. Blood, 116: e128–e138, 2010.
117.
OsmanA, FalkerK. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets, 22: 433–441, 2011.
118.
OuelletD, PlanteI, LandryP, BaratC, JanelleME, FlamandL, TremblayM, and ProvostP. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res, 36: 2353–2365, 2008.
119.
PanY, LiangH, LiuH, LiD, ChenX, LiL, ZhangCY, and ZenK. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol, 192: 437–446, 2014.
120.
ParalkarVR, MishraT, LuanJ, YaoY, KossenkovAV, AndersonSM, DunaginM, PimkinM, GoreM, SunD, KonuthulaN, RajA, AnX, MohandasN, BodineDM, HardisonRC, and WeissMJ. Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development. Blood, 123: 1927–1937, 2014.
PasquinelliAE, ReinhartBJ, SlackF, MartindaleMQ, KurodaMI, MallerB, HaywardDC, BallEE, DegnanB, MullerP, SpringJ, SrinivasanA, FishmanM, FinnertyJ, CorboJ, LevineM, LeahyP, DavidsonE, and RuvkunG. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 408: 86–89, 2000.
123.
PerreaultJ, PerreaultJP, and BoireG. Ro-associated Y RNAs in metazoans: Evolution and diversification. Mol Biol Evol, 24: 1678–1689, 2007.
124.
PitangaTN, de AragaoFL, RochaVC, MeirellesT, BorgesVM, GoncalvesMS, Pontes-de-CarvalhoLC, Noronha-DutraAA, and dos-SantosWL. Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells. BMC Cell Biol, 15: 21, 2014.
125.
PléH, LandryP, BenhamA, CoarfaC, GunaratnePH, and ProvostP. The repertoire and features of human platelet microRNAs. PLoS One, 7: e50746, 2012.
126.
PléH, MaltaisM, CorduanA, RousseauG, MadoreF, and ProvostP. Alteration of the platelet transcriptome in chronic kidney disease. Thromb Haemost, 108: 605–615, 2012.
127.
PluskotaE, WoodyNM, SzpakD, BallantyneCM, SolovievDA, SimonDI, and PlowEF. Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood, 112: 2327–2335, 2008.
128.
PontesTB, Moreira-NunesCF, MauesJH, LamaraoLM, de LemosJA, MontenegroRC, and BurbanoRM. The miRNA profile of platelets stored in a blood bank and its relation to cellular damage from storage. PLoS One, 10: e0129399, 2015.
129.
QinD, WangX, LiY, YangL, WangR, PengJ, EssandohK, MuX, PengT, HanQ, YuKJ, and FanGC. MicroRNA-223-5p and −3p cooperatively suppress necroptosis in ischemic/reperfused hearts. J Biol Chem, 291: 20247–20259, 2016.
130.
RandriamboavonjyV and FlemingI. All cut up! The consequences of calpain activation on platelet function. Vasc Pharmacol, 56: 210–215, 2012.
131.
RandriamboavonjyV, IsaakJ, ElgheznawyA, PistroschF, FrömelT, YinX, BadenhoopK, HeideH, MayrM, and FlemingI. Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes. Blood, 120: 415–423, 2012.
132.
RandriamboavonjyV, PistroschF, BolckB, SchwingerRH, DixitM, BadenhoopK, CohenRA, BusseR, and FlemingI. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone. Circulation, 117: 52–60, 2008.
133.
RepettoE, LichtensteinL, HizirZ, TekayaN, BenahmedM, RuidavetsJB, ZaragosiLE, PerretB, BouchareychasL, GenouxA, LotteR, RuimyR, FerrieresJ, BarbryP, MartinezLO, and TrabucchiM. RNY-derived small RNAs as a signature of coronary artery disease. BMC Med, 13: 259, 2015.
134.
RomaniaP, LulliV, PelosiE, BiffoniM, PeschleC, and MarzialiG. MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol, 143: 570–580, 2008.
135.
RowleyJW, ChappazS, CorduanA, ChongMM, CampbellR, KhouryA, ManneBK, WurtzelJG, MichaelJV, GoldfingerLE, MumawMM, NiemanMT, KileBT, ProvostP, and WeyrichAS. Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets. Blood, 127: 1743–1751, 2016.
136.
RutjesSA, van der HeijdenA, UtzPJ, van VenrooijWJ, and PruijnGJM. Rapid nucleolytic degradation of the small cytoplasmic Y RNAs during apoptosis. J Biol Chem, 274: 24799–24807, 1999.
137.
SattlerM, SalgiaR, ShrikhandeG, VermaS, UemuraN, LawSF, GolemisEA, and GriffinJD. Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1). J Biol Chem, 272: 14320–14326, 1997.
138.
SchoberA, Nazari-JahantighM, WeiY, BidzhekovK, GremseF, GrommesJ, MegensRT, HeyllK, NoelsH, HristovM, WangS, KiesslingF, OlsonEN, and WeberC. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med, 20: 368–376, 2014.
139.
SchulteC, MolzS, AppelbaumS, KarakasM, OjedaF, LauDM, HartmannT, LacknerKJ, WestermannD, SchnabelRB, BlankenbergS, and ZellerT. miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease. PLoS One, 10: e0145930, 2015.
140.
This reference has been deleted.
141.
SebastianiG, NigiL, GriecoGE, MancarellaF, VentrigliaG, and DottaF. Circulating microRNAs and diabetes mellitus: A novel tool for disease prediction, diagnosis, and staging?. J Endocrinol Invest, 40: 591–610, 2017.
142.
ShanZ, QinS, LiW, WuW, YangJ, ChuM, LiX, HuoY, SchaerGL, WangS, and ZhangC. An endocrine genetic signal between blood cells and vascular smooth muscle cells: Role of microRNA-223 in smooth muscle function and atherogenesis. J Am Coll Cardiol, 65: 2526–2537, 2015.
143.
ShengJ and XuZ. Three decades of research on angiogenin: A review and perspective. Acta Biochim Biophys Sin (Shanghai), 48: 399–410, 2016.
144.
ShiL, FisslthalerB, ZippelN, FromelT, HuJ, ElgheznawyA, HeideH, PoppR, and FlemingI. MicroRNA-223 antagonizes angiogenesis by targeting beta1 integrin and preventing growth factor signaling in endothelial cells. Circ Res, 113: 1320–1330, 2013.
145.
ShiL, KojonazarovB, ElgheznawyA, PoppR, DahalBK, BöhmM, PullamsettiSS, GhofraniHA, GödeckeA, JungmannA, KatusHA, MüllerOJ, SchermulyRT, FisslthalerB, SeegerW, and FlemingI. miR-223-IGF-IR signaling in hypoxia- and load-induced right ventricular failure: A novel therapeutic approach. Cardiovasc Res, 111: 184–193, 2016.
146.
ShiR, GeL, ZhouX, JiWJ, LuRY, ZhangYY, ZengS, LiuX, ZhaoJH, ZhangWC, JiangTM, and LiYM. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res, 131: 508–513, 2013.
147.
SimonLM, EdelsteinLC, NagallaS, WoodleyAB, ChenES, KongX, MaL, FortinaP, KunapuliS, HolinstatM, McKenzieSE, DongJF, ShawCA, and BrayPF. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood, 123: e37–e45, 2014.
148.
SondermeijerBM, BakkerA, HallianiA, de RondeMW, MarquartAA, TijsenAJ, MuldersTA, KokMG, BattjesS, MaiwaldS, SivapalaratnamS, TripMD, MoerlandPD, MeijersJC, CreemersEE, and Pinto-SietsmaSJ. Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*. PLoS One, 6: e25946, 2011.
149.
StarczynowskiDT, KuchenbauerF, ArgiropoulosB, SungS, MorinR, MuranyiA, HirstM, HoggeD, MarraM, WellsRA, BucksteinR, LamW, HumphriesRK, and KarsanA. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med, 16: 49–58, 2010.
150.
StratzC, NuhrenbergT, FiebichBL, AmannM, KumarA, BinderH, HoffmannI, ValinaC, HochholzerW, TrenkD, and NeumannFJ. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients. Thromb Haemost, 111: 902–911, 2014.
151.
StratzC, NuhrenbergTG, BinderH, ValinaCM, TrenkD, HochholzerW, NeumannFJ, and FiebichBL. Micro-array profiling exhibits remarkable intra-individual stability of human platelet micro-RNA. Thromb Haemost, 107: 634–641, 2012.
152.
SuJL, ChenPS, JohanssonG, and KuoML. Function and regulation of let-7 family microRNAs. Microrna, 1: 34–39, 2012.
153.
SunderlandN, SkroblinP, BarwariT, HuntleyRP, LuR, JoshiA, LoveringRC, and MayrM. MicroRNA biomarkers and platelet reactivity. Circ Res, 120: 418, 2017.
TakanoE, ParkYH, KitaharaA, YamagataY, KannagiR, and MurachiT. Distribution of calpains and calpastatin in human blood cells. Biochem Int, 16: 391–395, 1988.
156.
TanY, SangfeltO, and SpruckC. The Fbxw7/hCdc4 tumor suppressor in human cancer. Cancer Lett, 271: 1–12, 2008.
157.
TheryC, ZitvogelL, and AmigorenaS. Exosomes: Composition, biogenesis and function. Nat Rev Immunol, 2: 569–579, 2002.
158.
ThuringerD, BoucherJ, JegoG, PernetN, CronierL, HammannA, SolaryE, and GarridoC. Transfer of functional microRNAs between glioblastoma and microvascular endothelial cells through gap junctions. Oncotarget, 7: 73925–73934, 2016.
159.
TolonenAM, MaggaJ, SzaboZ, ViitalaP, GaoE, MoilanenAM, OhukainenP, VainioL, KochWJ, KerkelaR, RuskoahoH, and SerpiR. Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice. Pharmacol Res Perspect, 2: e00056, 2014.
160.
TranNT, SuH, Khodadadi-JamayranA, LinS, ZhangL, ZhouD, PawlikKM, TownesTM, ChenY, MulloyJC, and ZhaoX. The AS-RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation. EMBO Rep, 17: 887–900, 2016.
161.
TsaiMC, ManorO, WanY, MosammaparastN, WangJK, LanF, ShiY, SegalE, and ChangHY. Long noncoding RNA as modular scaffold of histone modification complexes. Science, 329: 689–693, 2010.
162.
TurchinovichA, TonevitskyAG, and BurwinkelB. Extracellular miRNA: A collision of two paradigms. Trends Biochem Sci, 41: 883–892, 2016.
163.
TurchinovichA, WeizL, LangheinzA, and BurwinkelB. Characterization of extracellular circulating microRNA. Nucleic Acids Res, 39: 7223–7233, 2011.
164.
ValadiH, EkstromK, BossiosA, SjostrandM, LeeJJ, and LotvallJO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 9: 654–659, 2007.
165.
VenckenSF, GreeneCM, and McKiernanPJ. Non-coding RNA as lung disease biomarkers. Thorax, 70: 501–503, 2015.
166.
VerschoorA and LangerHF. Crosstalk between platelets and the complement system in immune protection and disease. Thromb Haemost, 110: 910–919, 2013.
167.
VickersKC, PalmisanoBT, ShoucriBM, ShamburekRD, and RemaleyAT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol, 13: 423–433, 2011.
168.
ViereckJ and ThumT. Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ Res, 120: 381, 2017.
169.
WadhawanV, KarimZA, MukhopadhyayS, GuptaR, DikshitM, and DashD. Platelet storage under in vitro condition is associated with calcium-dependent apoptosis-like lesions and novel reorganization in platelet cytoskeleton. Arch Biochem Biophys, 422: 183–190, 2004.
170.
WagnerJ, RiwantoM, BeslerC, KnauA, FichtlschererS, RöxeT, ZeiherAM, LandmesserU, and DimmelerS. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler Thromb Vasc Biol, 33: 1392, 2013.
171.
WangK, YuanY, ChoJH, McClartyS, BaxterD, and GalasDJ. Comparing the microRNA spectrum between serum and plasma. PLoS One, 7: e41561, 2012.
172.
WangK, ZhangS, WeberJ, BaxterD, and GalasDJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res, 38: 7248–7259, 2010.
173.
WangKJ, ZhaoX, LiuYZ, ZengQT, MaoXB, LiSN, ZhangM, JiangC, ZhouY, QianC, FengKG, GuanHQ, TangTT, ChengX, and ChenZJ. Circulating miR-19b-3p, miR-134-5p and miR-186-5p are promising novel biomarkers for early diagnosis of acute myocardial infarction. Cell Physiol Biochem, 38: 1015–1029, 2016.
174.
WangS, AuroraAB, JohnsonBA, QiX, McAnallyJ, HillJA, RichardsonJA, Bassel-DubyR, and OlsonEN. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell, 15: 261–271, 2008.
175.
WangY, ZhangY, HuangJ, ChenX, GuX, WangY, ZengL, and YangGY. Increase of circulating miR-223 and insulin-like growth factor-1 is associated with the pathogenesis of acute ischemic stroke in patients. BMC Neurol, 14: 77, 2014.
176.
WardJA, EsaN, PidikitiR, FreedmanJE, KeaneyJF, TanriverdiK, VitsevaO, AmbrosV, LeeR, and McManusDD. Circulating cell and plasma microRNA profiles differ between non-ST-segment and ST-segment-elevation myocardial infarction. Fam Med Med Sci Res, 2: 108, 2013.
177.
WilleitP, ZampetakiA, DudekK, KaudewitzD, KingA, KirkbyNS, Crosby-NwaobiR, ProkopiM, DrozdovI, LangleySR, SivaprasadS, MarkusHS, MitchellJA, WarnerTD, KiechlS, and MayrM. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res, 112: 595–600, 2013.
178.
WongLL, ArmugamA, SepramaniamS, KarolinaDS, LimKY, LimJY, ChongJP, NgJY, ChenYT, ChanMM, ChenZ, YeoPS, NgTP, LingLH, SimD, LeongKT, OngHY, JaufeerallyF, WongR, ChaiP, LowAF, LamCS, JeyaseelanK, and RichardsAM. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail, 17: 393–404, 2015.
179.
WongLL, WangJ, LiewOW, RichardsAM, and ChenYT. MicroRNA and heart failure. Int J Mol Sci, 17: 502, 2016.
180.
YamasakiS, IvanovP, HuGF, and AndersonP. Angiogenin cleaves tRNA and promotes stress-induced translational repression. J Cell Biol, 185: 35–42, 2009.
181.
YangS, ZhaoJ, ChenY, and LeiM. Biomarkers associated with ischemic stroke in diabetes mellitus patients. Cardiovasc Toxicol, 16: 213–222, 2016.
182.
YangY, CaiY, WuG, ChenX, LiuY, WangX, YuJ, LiC, ChenX, JosePA, ZhouL, and ZengC. Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. Clin Sci (Lond), 129: 675–685, 2015.
183.
YinKJ, HamblinM, and ChenYE. Non-coding RNAs in cerebral endothelial pathophysiology: Emerging roles in stroke. Neurochem Int, 77: 9–16, 2014.
184.
YingW, TsengA, ChangRC, MorinA, BrehmT, TriffK, NairV, ZhuangG, SongH, KanameniS, WangH, GoldingMC, BazerFW, ChapkinRS, SafeS, and ZhouB. MicroRNA-223 is a crucial mediator of PPARã-regulated alternative macrophage activation. J Clin Invest, 125: 4149–4159, 2015.
185.
YuCH, XuCF, and LiYM. Association of MicroRNA-223 expression with hepatic ischemia/reperfusion injury in mice. Dig Dis Sci, 54: 2362–2366, 2009.
186.
YuS, DengG, QianD, XieZ, SunH, HuangD, and LiQ. Detection of apoptosis-associated microRNA in human apheresis platelets during storage by quantitative real-time polymerase chain reaction analysis. Blood Transfus, 12: 541–547, 2014.
187.
YuXY, ChenJY, ZhengZW, WuH, LiLW, ZhangZW, ChenZH, LinQX, HanYL, and ZhongSL. Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention. EuroIntervention, 9: 546–554, 2013.
188.
YuanJY, WangF, YuJ, YangGH, LiuXL, and ZhangJW. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J Cell Mol Med, 13: 4551–4559, 2009.
189.
ZampetakiA, KiechlS, DrozdovI, WilleitP, MayrU, ProkopiM, MayrA, WegerS, OberhollenzerF, BonoraE, ShahA, WilleitJ, and MayrM. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res, 107: 810–817, 2010.
190.
ZampetakiA, WilleitP, BurrS, YinX, LangleySR, KiechlS, KleinR, RossingP, ChaturvediN, and MayrM. Angiogenic microRNAs linked to incidence and progression of diabetic retinopathy in type 1 diabetes. Diabetes, 65: 216–227, 2016.
191.
ZampetakiA, WilleitP, TillingL, DrozdovI, ProkopiM, RenardJM, MayrA, WegerS, SchettG, ShahA, BoulangerCM, WilleitJ, ChowienczykPJ, KiechlS, and MayrM. Prospective study on circulating microRNAs and risk of myocardial infarction. J Am Coll Cardiol, 60: 290–299, 2012.
192.
ZerneckeA, BidzhekovK, NoelsH, ShagdarsurenE, GanL, DeneckeB, HristovM, KoppelT, JahantighMN, LutgensE, WangS, OlsonEN, SchoberA, and WeberC. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal, 2: ra81, 2009.
193.
ZhaiPF, WangF, SuR, LinHS, JiangCL, YangGH, YuJ, and ZhangJW. The regulatory roles of microRNA-146b-5p and its target platelet-derived growth factor receptor α (PDGFRA) in erythropoiesis and megakaryocytopoiesis. J Biol Chem, 289: 22600–22613, 2014.
194.
ZhangH, KolbFA, BrondaniV, BillyE, and FilipowiczW. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J, 21: 5875–5885, 2002.
195.
ZhangK, ShiZM, ChangYN, HuZM, QiHX, and HongW. The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene, 547: 1–9, 2014.
196.
ZhangX, McGeochSC, JohnstoneAM, HoltropG, SneddonAA, MacRurySM, MegsonIL, PearsonDW, AbrahamP, DeRB, LobleyGE, and O'KennedyN. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J Thromb Thrombolysis, 37: 455–463, 2014.
ZhangY, SunX, IcliB, and FeinbergMW. Emerging roles for microRNAs in diabetic microvascular disease—Novel targets for therapy. Endocr Rev, 738: 145–168, 2017.
199.
ZhuangG, MengC, GuoX, CherukuPS, ShiL, XuH, LiH, WangG, EvansAR, SafeS, WuC, and ZhouB. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation, 125: 2892–2903, 2012.
200.
ZongL, ZhuY, LiangR, and ZhaoHB. Gap junction mediated miRNA intercellular transfer and gene regulation: A novel mechanism for intercellular genetic communication. Sci Rep, 6: 19884, 2016.
